Ignite Creation Date:
2024-05-06 @ 3:23 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04610528
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-23
First Post:
2020-10-27
Brief Title:
A Window-of-opportunity Study of U3-1402 a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression
Sponsor:
Organization:
SOLTI Breast Cancer Research Group